Uniwersytet Medyczny w Białymstoku – publiczna uczelnia o profilu medycznym powstała 3 lutego 1950 roku. Siedzibę Uniwersytetu stanowi spalony w czasie wojny, a następnie odbudowany pałac Branickich.

During the past decade, Univ. Clinic Hosp, Bialystok conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Univ. Clinic Hosp, Bialystok" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań" with 1 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored, "Polish Adult Leukemia Group" with 1 trials sponsored and "University Hospital, Toulouse" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univ. Clinic Hosp, Bialystok" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Univ. Clinic Hosp, Bialystok" are "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Lupus Nephritis" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Angioplasty" (1 trials). Many other conditions were trialed in "Univ. Clinic Hosp, Bialystok" in a lesser frequency.

Most popular intervention types in "Univ. Clinic Hosp, Bialystok" are "Drug" (10 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (3 trials), "A arm (CLAG-M)" (1 trials), "A arm (DA-90)" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univ. Clinic Hosp, Bialystok" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Univ. Clinic Hosp, Bialystok". 1 are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Univ. Clinic Hosp, Bialystok, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Univ. Clinic Hosp, Bialystok, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".